CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 64 filers reported holding CATALYST BIOSCIENCES INC in Q1 2019. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,273,000 | -33.4% | 462,852 | 0.0% | 0.08% | -27.9% |
| Q2 2019 | $3,411,000 | -9.1% | 462,852 | 0.0% | 0.10% | -19.4% |
| Q1 2019 | $3,754,000 | +93.4% | 462,852 | +88.2% | 0.13% | +50.0% |
| Q4 2018 | $1,941,000 | -26.8% | 246,000 | 0.0% | 0.09% | -11.3% |
| Q3 2018 | $2,652,000 | -7.6% | 246,000 | 0.0% | 0.10% | -18.5% |
| Q2 2018 | $2,871,000 | – | 246,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,635,014 | $10,830,000 | 4.93% |
| 22NW, LP | 1,429,242 | $5,874,000 | 1.75% |
| Ghost Tree Capital, LLC | 1,000,000 | $4,110,000 | 1.20% |
| Sio Capital Management, LLC | 623,892 | $2,564,000 | 0.82% |
| ACUTA CAPITAL PARTNERS, LLC | 365,000 | $1,500,000 | 0.53% |
| Nantahala Capital Management | 2,432,212 | $9,996,000 | 0.32% |
| Parkman Healthcare Partners LLC | 133,449 | $548,000 | 0.14% |
| Ikarian Capital, LLC | 454,346 | $1,867,000 | 0.13% |
| Orbimed Advisors | 2,711,600 | $11,145,000 | 0.12% |
| AlphaCentric Advisors LLC | 114,000 | $469,000 | 0.12% |